'Dr tb' presentation slideshows

807 views • 53 slides

DR-TB

DR-TB. Dr. Magdy Fawzy NTP, EGYPT PAL Coordinator. Causes of drug-resistant tuberculosis: From a microbiological perspective, resistance is caused by a genetic mutation.

624 views • 49 slides

Drug Resistant Tuberculosis (DR-TB): An Update

Drug Resistant Tuberculosis (DR-TB): An Update. Dr. Dick Menzies Montreal Chest Institute. Definitions. Primary DR: Resistance in person treated <1 month or not at all Acquired DR: Resistance in person treated > 1 month Mono-drug resistance: Resistance to 1 drug

968 views • 49 slides

Special Situations in the Treatment of MDR TB

Special Situations in the Treatment of MDR TB. Dr. Ashraf Abdulhaseeb Chest Diseases Consultant Chief of DR-TB center, Abbassia Chest Hospital. MDR-TB and children. When DST is available, it should be used to guide therapy.

509 views • 39 slides

Thank you for viewing this presentation.

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author. 2010 by the author. MDR- and XDR-TB: prevention, treatment and control

454 views • 35 slides

Linking IMAI with palliative care in M/XDR-TB

Linking IMAI with palliative care in M/XDR-TB. Aka "Using IMAI tools for palliative care of M/XDR TB" Drs Akiiki Bitalabeho and Sandy Gove for the IMAI team and palliative care expert group. Palliative care: symptom management (during acute and chronic care) and end-of-life care.

427 views • 27 slides

405 views • 26 slides

Treatment strategy & Regimens used in Egypt

Treatment strategy & Regimens used in Egypt. Different treatment strategies available. Standardized treatment. Designing this treatment regimen depends on representative DRS data. All patients in a patient group or category receive the same regimen.

360 views • 25 slides

Monitoring and Evaluation of MDR TB

417 views • 25 slides

Drug Resistant Tuberculosis: An Overview

Drug Resistant Tuberculosis: An Overview. July 14, 2014, Pokhara, Nepal Dr. Sharat Chandra Verma Chief Consultant Chest Physician National TB Centre Nepal. Some definitions.

492 views • 24 slides

Partnerships to Prevent, Find and Treat TB/DRTB and HIV

Partnerships to Prevent, Find and Treat TB/DRTB and HIV. 12 October 2010 Prof Harry Hausler, Director. Overview. TB/HIV Care Association Challenges with drug-resistant (DR)-TB Decentralised DR-TB - Khayelitsha Partnerships to prevent, find and treat DR-TB

356 views • 23 slides

Magnitude and management globally and nationally

Magnitude and management globally and nationally. Global Magnitude of DR-TB Problem. The WHO, Stop TB Department, estimates the number of incident cases (including new and re-treatment cases) occurring worldwide in 2003 alone to be 458 000.

294 views • 22 slides

TB/HIV integration: A field perspective

TB/HIV integration: A field perspective. Gilles Van Cutsem. TB + HIV = double trouble. In HIV+ risk of TB is up to 26 x higher TB is the first cause of death among HIV+ TB deteriorates more rapidly if HIV+ TB is more difficult to diagnose in HIV+

344 views • 21 slides

CLINICAL DIAGNOSTIC TB LABORATORY

CLINICAL DIAGNOSTIC TB LABORATORY. Alexander Sloutsky, Director University of Massachusetts Supranational Reference TB Laboratory Boston, MA. ASSESSMENT OF THE TB LABORATORY SERVICES. Currently used methods and new methods implementation Turn-around time (TAT) and CDC guidelines

503 views • 20 slides

COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS

COUNTRY XEPERIENCE AND RESPONSE TO MDR AND XDR TUBERCULOSIS. PRESENTED AT THE WHO TB/HIV PLANNING MEETING, ADDIS ABBABA, 11-12, NOVEMBER 2008 BY MS GUGU SHONGWE SWAZILAND NATIONAL TUBERCULOSIS CONTROL PROGRAMME. PRESENTATION OUTLINE. TB SITUATION IN SWAZILAND

215 views • 13 slides

TB/HIV COMMUNITY MOBILIZATION IN AFRICA : Ongoing activities, achievements and challenges

TB/HIV COMMUNITY MOBILIZATION IN AFRICA : Ongoing activities, achievements and challenges. Paula Akugizibwe , AIDS and Rights Alliance for Southern AFrica TB/HIV Core Group Meeting 11 November 2008 Addis Ababa. Ongoing Activities (1). A few examples of: Community education:

246 views • 10 slides

Identifying Cases of MDR-TB

Identifying Cases of MDR-TB. Session 3. Old WHO recommendations. New 2010 WHO recommendations.

180 views • 10 slides

Global Drug Facility

An innovative approach to supplying anti-TB drugs. Andrea de Lucia Team Leader Applications, Review, and Monitoring 4 November 2010. Global Drug Facility. What is the GDF?. An initiative of the Global Partnership to Stop TB (operational in 2002)

362 views • 8 slides

(T)DR-TB

250 views • 7 slides

Laboratory and Diagnosis

Laboratory and Diagnosis. Dr R Ramachandran 5 th Joint International Monitoring Mission to Review NTP Thailand. Situation. Functional quality assured nationwide smear microscopy network (1081)

199 views • 6 slides